12:00 AM
Sep 05, 2013
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Cancer c-Myc (MYC); mammalian target of rapamycin (mTOR; FRAP; RAFT1); 3-phosphoinositide dependent...

Read the full 183 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >